Represented Lasergen, Inc., an emerging biotechnology company specializing in innovative next-generation sequencing technology, in an $80 million investment by Agilent Technologies Inc., a life sciences, diagnostics, and applied chemicals company, in exchange for a 48 percent stake in Lasergen.
Stake Acquisition of Lasergen, Inc.
Participating Lawyers
